Cue Biopharma shares owned by UBS Group
Historical chart of UBS Group investment in Cue Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Cue Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Cue Biopharma by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $143k | 199k | 0.72 |
| 2025-06-30 | $200k | 293k | 0.68 |
| 2025-03-31 | $56k | 61k | 0.91 |
| 2024-12-31 | $64k | 58k | 1.09 |
| 2024-09-30 | $56k | 74k | 0.76 |
| 2024-06-30 | $73k | 59k | 1.24 |
| 2024-03-31 | $176k | 93k | 1.89 |
| 2023-12-31 | $262k | 99k | 2.64 |
| 2023-09-30 | $182k | 79k | 2.30 |
| 2023-06-30 | $293k | 80k | 3.65 |
| 2023-03-31 | $207k | 58k | 3.57 |
| 2022-12-31 | $69k | 24k | 2.85 |
| 2022-09-30 | $54k | 24k | 2.24 |
| 2022-06-30 | $73k | 28k | 2.57 |
| 2022-03-31 | $133k | 26k | 5.19 |
| 2021-12-31 | $1.2M | 109k | 11.30 |
| 2021-09-30 | $855k | 59k | 14.59 |
| 2021-06-30 | $314k | 27k | 11.62 |
| 2021-03-31 | $640k | 52k | 12.20 |
| 2020-12-31 | $288k | 23k | 12.77 |
| 2020-09-30 | $325k | 22k | 15.05 |
| 2020-06-30 | $529k | 22k | 24.50 |
| 2020-03-31 | $439k | 31k | 14.18 |
| 2019-12-31 | $933k | 59k | 15.86 |
| 2019-09-30 | $409k | 49k | 8.42 |
| 2019-06-30 | $326k | 36k | 8.99 |
| 2019-03-31 | $274k | 30k | 9.01 |
| 2018-12-31 | $175k | 37k | 4.69 |
| 2018-09-30 | $235k | 26k | 9.00 |
| 2018-06-30 | $279k | 23k | 12.06 |
| 2018-03-31 | $53k | 3.7k | 14.23 |